Abstract
The antitumor activity of the sea snake venom (Lapemis curtus) was evaluated against Ehrlich's ascites carcinoma (EAC) in Swiss albino mice and HeLa and Hep2 tumor cell cultures. Among the different doses tested, 6.50 μg/ml at 24 h was found to effectively inhibit cancer cell proliferation. The same dose on EAC-bearing mice by i.p. injection significantly reduced the tumor growth and was demonstrated by increased life span of the mice by 201.25%.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 157-161 |
| Number of pages | 5 |
| Journal | Toxicon |
| Volume | 51 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2008 |
| Externally published | Yes |
Keywords
- Antitumor
- Cytotoxicity
- Ehrlich's ascites carcinoma
- Lapemis curtus
- Sea snake venom
ASJC Scopus subject areas
- Toxicology
Fingerprint
Dive into the research topics of 'Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS